Dark Walnut (Juglans nigra)

Black walnut (Juglans nigra) contains juglone, a naphthoquinone compound that inhibits NF-κB signaling and induces oxidative stress selectively in cancer cells. Its hull, leaves, and bark are rich in ellagitannins and phenolic acids that drive its antioxidant and anti-inflammatory properties.

Origin & History

Black walnut (Juglans nigra) is a tree native to North America whose kernels (seeds) contain diverse phenolic compounds and metabolites. The kernels are typically extracted using methanolic or aqueous methods to concentrate bioactive compounds including flavonoids, ellagic acid derivatives, and other polyphenol-rich antioxidants.

Historical & Cultural Context

No information on traditional medicinal use was provided in the research results. The available studies focus exclusively on modern biomedical research without discussing historical applications.

Health Benefits

• Anti-inflammatory effects: Dose-dependently reduced TNF-α, IL-1β, and IL-6 in cell studies (in vitro evidence only)
• Antioxidant activity: Phenolic compounds induced antioxidant response elements in high-throughput screening (preliminary evidence)
• Potential cancer cell inhibition: Specific compounds showed IC₅₀ values <10 µM against A549 lung cancer cells (in vitro evidence only)
• Possible cognitive support: Protein hydrolysate reduced inflammatory markers in Alzheimer's mouse models (animal evidence only)
• Gut microbiota modulation: May increase beneficial Firmicutes species (limited animal evidence)

How It Works

Juglone, the primary bioactive naphthoquinone in Juglans nigra, inhibits IκB kinase (IKK), thereby suppressing NF-κB nuclear translocation and downstream transcription of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. Ellagitannins and gallic acid derivatives activate the Nrf2/ARE (antioxidant response element) pathway by promoting Nrf2 dissociation from Keap1, upregulating cytoprotective enzymes such as heme oxygenase-1 (HO-1) and glutathione S-transferase. Juglone also inhibits mitochondrial complex I and induces ROS-mediated apoptosis in rapidly proliferating cells, which underlies its selective cytotoxicity against certain cancer cell lines.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses for black walnut (Juglans nigra) were found in the available research. All evidence comes from in vitro studies using human cell lines and animal models with induced disease states.

Clinical Summary

The evidence base for Juglans nigra is largely preclinical, consisting of in vitro cell studies and limited animal models rather than randomized controlled trials in humans. Cell-based assays demonstrated dose-dependent reductions in TNF-α, IL-1β, and IL-6 concentrations, while high-throughput screening identified activation of antioxidant response elements by phenolic fractions. Animal studies have shown antimicrobial effects of juglone against Candida albicans and certain gram-positive bacteria, but effective concentrations have not been validated in human pharmacokinetic studies. No peer-reviewed human clinical trials with defined sample sizes and standardized Juglans nigra extracts have been published to date, making efficacy claims in humans preliminary at best.

Nutritional Profile

Black walnut (Juglans nigra) nutritional composition per 100g of dried kernel: Protein: ~24g (high quality, containing all essential amino acids including arginine ~2.3g); Total fat: ~59g (predominantly polyunsaturated fatty acids — linoleic acid omega-6 ~34g, alpha-linolenic acid omega-3 ~3.3g, oleic acid omega-9 ~15g); Carbohydrates: ~10g; Dietary fiber: ~6.8g. Key micronutrients: Magnesium ~201mg (48% DV), Phosphorus ~513mg (41% DV), Zinc ~3.4mg (31% DV), Copper ~1.4mg (156% DV), Manganese ~4.0mg (174% DV), Iron ~3.1mg (17% DV), Potassium ~523mg (11% DV), Selenium ~17µg. Vitamins: Vitamin B6 ~0.58mg (34% DV), Thiamine ~0.27mg (23% DV), Folate ~31µg (8% DV), Vitamin E (gamma-tocopherol predominantly) ~21mg — notably higher gamma-tocopherol than alpha-tocopherol. Bioactive compounds: Juglone (5-hydroxy-1,4-naphthoquinone) is the signature compound, concentrated in hull/husk (~0.1–0.5% dry weight of hull); Tannins including ellagitannins (glansrins, pedunculagin) and hydrolyzable tannins; Ellagic acid and gallic acid as primary polyphenols; Quercetin and kaempferol as flavonoids; Melatonin detected at trace levels (~3.5ng/g). Hull extract contains significantly higher phenolic content (~150–400mg GAE/g dry extract) compared to kernel (~15–30mg GAE/g). Bioavailability notes: Juglone has limited oral bioavailability due to rapid metabolism; ellagitannins are hydrolyzed in the gut to ellagic acid, which is further converted by gut microbiota to urolithins (urolithin A, B) — conversion is microbiome-dependent and variable among individuals (estimated 25–80% of population are 'urolithin producers'); phytate content (~4–5% of dry weight) reduces mineral bioavailability, particularly zinc and iron; fat-soluble compounds including tocopherols show improved absorption when consumed with dietary fat; the hull (outer green husk) is not typically consumed as food but is used medicinally and contains the highest concentration of bioactive compounds.

Preparation & Dosage

No clinically studied human dosages are available. Animal studies used 20 mg/kg walnut phenolic extract and 200-800 mg/kg protein hydrolysate. In vitro studies tested methanolic extracts at 0.1-10 mg/ml concentrations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Ellagic acid, Green tea extract, Curcumin, Resveratrol

Safety & Interactions

Juglone is a known plant cytotoxin and can cause oxidative damage to red blood cells at high doses, posing a theoretical risk of hemolytic anemia, particularly in individuals with G6PD deficiency. Black walnut preparations may inhibit cytochrome P450 3A4 and 2C9 enzymes, potentially raising plasma levels of drugs such as warfarin, cyclosporine, and statins metabolized by these pathways. Topical exposure to black walnut hull can cause contact dermatitis and mucosal irritation, and ingestion of concentrated hull extracts has been associated with GI upset, nausea, and diarrhea. Juglans nigra is contraindicated during pregnancy and breastfeeding due to insufficient safety data and the theoretical uterotonic activity of juglone; individuals with tree nut allergies should also avoid supplementation.